NASDAQ:FLGT - Fulgent Genetics Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$4.52 -0.34 (-7.00 %)
(As of 07/16/2018 04:55 AM ET)
Previous Close$4.52
Today's Range$4.43 - $4.98
52-Week Range$2.72 - $7.04
Volume17,449 shs
Average Volume8,259 shs
Market Capitalization$80.86 million
P/E Ratio-41.09
Dividend YieldN/A
Beta0.14
Fulgent Genetics logoFulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves hospitals and medical institutions. It markets its tests through internal sales force, as well as through independent sales representatives in the United States, Canada, the People's Republic of China, and internationally. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California.

Receive FLGT News and Ratings via Email

Sign-up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Medical laboratories
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:FLGT
CUSIPN/A
Phone626-350-0537

Debt

Debt-to-Equity RatioN/A
Current Ratio15.03
Quick Ratio15.03

Price-To-Earnings

Trailing P/E Ratio-41.09
Forward P/E Ratio-15.59
P/E GrowthN/A

Sales & Book Value

Annual Sales$18.73 million
Price / Sales4.32
Cash Flow$0.0035 per share
Price / Cash1,278.71
Book Value$3.04 per share
Price / Book1.49

Profitability

EPS (Most Recent Fiscal Year)($0.11)
Net Income$-2,510,000.00
Net Margins-26.57%
Return on Equity-7.62%
Return on Assets-7.22%

Miscellaneous

Employees98
Outstanding Shares17,890,000
Market Cap$80.86

The Truth About Cryptocurrencies

Fulgent Genetics (NASDAQ:FLGT) Frequently Asked Questions

What is Fulgent Genetics' stock symbol?

Fulgent Genetics trades on the NASDAQ under the ticker symbol "FLGT."

How were Fulgent Genetics' earnings last quarter?

Fulgent Genetics Inc (NASDAQ:FLGT) announced its quarterly earnings results on Monday, May, 7th. The company reported ($0.06) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.04) by $0.02. The business earned $4.65 million during the quarter. Fulgent Genetics had a negative net margin of 26.57% and a negative return on equity of 7.62%. View Fulgent Genetics' Earnings History.

When is Fulgent Genetics' next earnings date?

Fulgent Genetics is scheduled to release their next quarterly earnings announcement on Monday, August, 6th 2018. View Earnings Estimates for Fulgent Genetics.

What price target have analysts set for FLGT?

2 equities research analysts have issued 12-month price objectives for Fulgent Genetics' stock. Their predictions range from $5.00 to $7.00. On average, they expect Fulgent Genetics' stock price to reach $6.00 in the next year. This suggests a possible upside of 32.7% from the stock's current price. View Analyst Ratings for Fulgent Genetics.

What is the consensus analysts' recommendation for Fulgent Genetics?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fulgent Genetics in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."

Who are some of Fulgent Genetics' key competitors?

Who are Fulgent Genetics' key executives?

Fulgent Genetics' management team includes the folowing people:
  • Mr. Ming Hsieh, Chairman, CEO & Pres (Age 62)
  • Mr. Paul Kim, Chief Financial Officer (Age 51)
  • Dr. Han Lin Gao, Chief Scientific Officer & Lab Director (Age 51)
  • Joe Roach, VP

When did Fulgent Genetics IPO?

(FLGT) raised $60 million in an initial public offering on Thursday, September 29th 2016. The company issued 4,600,000 shares at a price of $12.00-$14.00 per share. Credit Suisse and Piper Jaffray acted as the underwriters for the IPO and Raymond James and BTIG were co-managers.

Has Fulgent Genetics been receiving favorable news coverage?

News headlines about FLGT stock have been trending somewhat positive on Monday, Accern Sentiment Analysis reports. The research group identifies negative and positive press coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Fulgent Genetics earned a news impact score of 0.11 on Accern's scale. They also assigned media stories about the company an impact score of 45.17 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

How do I buy shares of Fulgent Genetics?

Shares of FLGT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Fulgent Genetics' stock price today?

One share of FLGT stock can currently be purchased for approximately $4.52.

How big of a company is Fulgent Genetics?

Fulgent Genetics has a market capitalization of $80.86 million and generates $18.73 million in revenue each year. The company earns $-2,510,000.00 in net income (profit) each year or ($0.11) on an earnings per share basis. Fulgent Genetics employs 98 workers across the globe.

How can I contact Fulgent Genetics?

Fulgent Genetics' mailing address is 4978 SANTA ANITA AVENUE, TEMPLE CITY CA, 91780. The company can be reached via phone at 626-350-0537 or via email at [email protected]


MarketBeat Community Rating for Fulgent Genetics (NASDAQ FLGT)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  104 (Vote Outperform)
Underperform Votes:  133 (Vote Underperform)
Total Votes:  237
MarketBeat's community ratings are surveys of what our community members think about Fulgent Genetics and other stocks. Vote "Outperform" if you believe FLGT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FLGT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.